A team of researchers at Texas A&M University, Northwestern University, and ImmunoGenesis has discovered a treatment for glioblastoma that has promising implications for the human version of the aggressive cancer form that ...
Aug 27, 2021
0
623
Several drugs already approved by the U.S. Food and Drug Administration (FDA) could potentially be used to alleviate the symptoms of COVID-19, biomedical researchers at Université de Montréal have found.
Dec 17, 2020
0
14
CRISPR/Cas9 genome editing is quickly revolutionizing biomedical research, but the new technology is not yet exact. The technique can inadvertently make excessive or unwanted changes in the genome and create off-target mutations, ...
Dec 8, 2016
0
143
A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. The Phase 1 clinical trial is examining the safety ...
May 23, 2018
0
187
In the largest study of its kind, involving more than 100,000 people, researchers at the Icahn School of Medicine at Mount Sinai have applied a novel machine learning method to identify 413 genetic associations with schizophrenia ...
Mar 25, 2019
0
254
People with 'neurotic' tendencies are more likely to be troubled by their tinnitus, a new study involving researchers at The University of Nottingham, has found.
Sep 27, 2013
0
0
One of the most significant genetic risk factors for developing Alzheimer's disease is a gene called APOE4, which is carried by almost half of all Alzheimer's patients. A new study from MIT shows that this gene has widespread ...
Mar 3, 2021
0
128
Ineffective group dynamics within research groups and research collaborations contribute to the unrealistic picture of the data generated in scientific research, according to Judith Rosmalen and Albertine Oldehinkel from ...
Dec 13, 2011
0
0
As more money has been spent on biomedical research in the United States over the past 50 years, there has been diminished return on investment in terms of life expectancy gains and new drug approvals, two Johns Hopkins Bloomberg ...
Aug 17, 2015
1
51
The new generation of incretin-based medicines will allow a coordinated action against the combination diabetes/obesity, also known as diabesity, in some cases with only a single weekly dose, and with the likelihood of additional ...
Oct 28, 2015
0
13
